Hepatitis B with HIV or hepatitis C: tests, medicines, and follow-up points

Why coinfection needs a separate plan

Hepatitis B, HIV, and hepatitis C can all spread through blood or sexual exposure, and all can affect the liver and long-term medicine plans. When a person has two or three of these infections, treatment order, medicine choice, stopping-risk, and liver monitoring become more complex.

This is not meant to create fear. It means that HBsAg, anti-HBc, anti-HBs, HBV DNA, HCV antibody or HCV RNA, HIV results, liver tests, and current medicines should be reviewed together instead of being handed to separate clinics one by one.

If you have HIV or are starting HIV treatment

People with HIV should confirm hepatitis B screening and vaccine assessment. NIH HIV/HBV coinfection guidance emphasizes that antiretroviral therapy often needs medicines active against HBV; common regimens may include tenofovir with lamivudine or emtricitabine. The exact regimen must be chosen by HIV or infectious disease clinicians based on kidney function, bone risk, resistance, and prior medicines.

Do not stop or split combination medicines on your own. Some HIV medicines also suppress HBV; stopping them suddenly can allow HBV to rebound and cause hepatitis flares. Ask directly: Does my HIV regimen also cover HBV? If my HIV medicines change, who will monitor HBV DNA and ALT?

If you are treating hepatitis C

Direct-acting antivirals have made hepatitis C treatment more effective, but the clinician still needs to know your hepatitis B results before treatment. CDC hepatitis C clinical care information reminds clinicians to assess HBV infection risk before HCV treatment because some people can have HBV reactivation during HCV therapy.

If you were ever HBsAg positive, anti-HBc positive, or uncertain about your HBV status, bring complete HBV serology and HBV DNA results before starting hepatitis C medicines. The clinician may arrange ALT, HBV DNA, or other liver monitoring before, during, and after HCV treatment, and may discuss HBV treatment if needed.

What to bring

Organize information into four groups. Hepatitis B: HBsAg, anti-HBs, anti-HBc, HBeAg/anti-HBe, HBV DNA. Hepatitis C: HCV antibody, HCV RNA, genotype, or past treatment records. HIV: HIV RNA, CD4, antiretroviral regimen, and resistance history. Liver and safety: ALT/AST, bilirubin, albumin, INR, platelets, creatinine/eGFR, urinalysis, liver ultrasound, or elastography.

Also bring a medicine list, including HIV medicines, hepatitis B medicines, hepatitis C medicines, tuberculosis medicines, seizure medicines, lipid medicines, herbs, supplements, and over-the-counter pain medicines. Coinfection care can be derailed by missed drug interactions or duplicate therapy.

Family and partner considerations

Coinfection does not change the basic hepatitis B fact that hugging, meals, handshakes, and shared toilets usually do not spread HBV. But sex partners and household members should still confirm hepatitis B screening and vaccination status. If HIV, hepatitis C, or other sexually transmitted infection risks are involved, ask about testing, prevention, and condom use according to local guidance.

Do not explain all infections as if they are the same. You can say: hepatitis B has a vaccine; family members can be screened and vaccinated. Hepatitis C is often curable. HIV has effective long-term treatment and prevention. Disclosure should consider privacy and safety, and clinicians, counselors, or patient organizations can help.

Questions to ask at follow-up

1. Have I had complete HBsAg, anti-HBc, anti-HBs, HCV RNA, and HIV testing?
2. Does my HIV regimen also treat HBV? If the regimen changes, how will HBV be monitored?
3. Before hepatitis C treatment, do I need HBV DNA testing or HBV treatment?
4. Could kidney function, bone risk, or cirrhosis affect medicine choice?
5. During treatment, how often should ALT, HBV DNA, HCV RNA, and HIV RNA be checked?
6. Which symptoms or results should make me contact the clinic the same day?
7. What screening, vaccination, or prevention counseling do partners or family members need?

Action checklist

Keep hepatitis B, hepatitis C, and HIV results in one folder. Before starting or changing HIV or hepatitis C medicines, proactively tell clinicians about hepatitis B results. Do not stop HBV-active HIV medicines or hepatitis B medicines on your own. Before HCV treatment, confirm whether HBV DNA and ALT monitoring are needed. Bring a complete medicine and supplement list to visits. Ask partners and household members to confirm hepatitis B screening and vaccination. Seek care promptly for jaundice, dark urine, marked fatigue, abdominal swelling, vomiting blood, black stools, or confusion.